Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hydrofarm Holdings (HYFM) Cash & Equivalents (2020 - 2025)

Hydrofarm Holdings' Cash & Equivalents history spans 6 years, with the latest figure at $6.3 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 75.84% year-over-year to $6.3 million; the TTM value through Dec 2025 reached $6.3 million, down 75.84%, while the annual FY2025 figure was $6.3 million, 75.84% down from the prior year.
  • Cash & Equivalents reached $6.3 million in Q4 2025 per HYFM's latest filing, down from $10.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $193.6 million in Q2 2021 to a low of $6.3 million in Q4 2025.
  • Average Cash & Equivalents over 5 years is $31.2 million, with a median of $24.3 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: soared 508.26% in 2021, then plummeted 86.34% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $26.6 million in 2021, then fell by 19.98% to $21.3 million in 2022, then surged by 42.37% to $30.3 million in 2023, then fell by 13.86% to $26.1 million in 2024, then plummeted by 75.84% to $6.3 million in 2025.
  • Per Business Quant, the three most recent readings for HYFM's Cash & Equivalents are $6.3 million (Q4 2025), $10.7 million (Q3 2025), and $11.0 million (Q2 2025).